stockportfolio.pro
Arcus Biosciences, Inc. Shares Outstanding 2016–2025
Arcus Biosciences, Inc. (RCUS) annual shares outstanding by fiscal year, computed from SEC filings.
| Fiscal year | Shares Outstanding | Change (YoY) |
|---|---|---|
| FY 2025 | 125.3M | +35.9% |
| FY 2024 | 92.2M | +22.1% |
| FY 2023 | 75.5M | +3.6% |
| FY 2022 | 72.9M | +3.0% |
| FY 2021 | 70.8M | +8.7% |
| FY 2020 | 65.1M | +41.8% |
| FY 2019 | 45.9M | +3.1% |
| FY 2018 | 44.5M | +988.7% |
| FY 2017 | 4.1M | — |
| FY 2016 | 0.0M | — |
Source: Arcus Biosciences, Inc. SEC filings — balance sheet (10-K), split-adjusted. Refreshed nightly.
See the full picture for Arcus Biosciences, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeArcus Biosciences, Inc. — frequently asked questions
What is Arcus Biosciences, Inc.'s shares outstanding?
Arcus Biosciences, Inc. (RCUS) reported shares outstanding of 125.3M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Arcus Biosciences, Inc.'s official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.